NSGO-CTU/HERO
Trial Description:
Characterization of High-Grade Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype – A Prospective Observational Study
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Recruiting
Contact person:
mraza